Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Masitinib in Combination With FOLFIRI Versus Masitinib Alone, Versus Best Supportive Care, in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

NCT03556956 is registered in ClinicalTrials.gov with AB Science as lead sponsor.

NCT NCT03556956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03556956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Masitinib in Combination With FOLFIRI Versus Masitinib Alone, Versus Best Supportive Care, in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer
Lead sponsor
AB Science
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2015
Completion date
December 31, 2020
Enrollment
219 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic